These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35022990)

  • 1. Inpatient Management of Pulmonary Embolism: Clinical Characteristics and Mortality in a High-Volume Tertiary Care Center.
    Mudrakola HV; Caples SM; Hyde RJ; McBane Ii RD; Ahmad SR
    J Thromb Thrombolysis; 2022 Jul; 54(1):145-152. PubMed ID: 35022990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
    Harvey JJ; Huang S; Uberoi R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013083. PubMed ID: 35938605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
    Matusov Y; Yaqoob M; Karumanchi A; Lipshutz HG; Dohad S; Steinberger J; Lopez A; Singh S; Tapson VF; Friedman O
    Thromb Res; 2023 May; 225():57-62. PubMed ID: 37003150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-assisted catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism.
    Kline TM; Rodino AM; Dorszynski A; Murray B; Cicci J; Iyer P
    J Thromb Thrombolysis; 2021 Jul; 52(1):130-137. PubMed ID: 32996083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pulmonary embolism response team's initial 20 month experience treating 87 patients with submassive and massive pulmonary embolism.
    Sista AK; Friedman OA; Dou E; Denvir B; Askin G; Stern J; Estes J; Salemi A; Winokur RS; Horowitz JM
    Vasc Med; 2018 Feb; 23(1):65-71. PubMed ID: 28920554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients.
    Eberle H; Lyn R; Knight T; Hodge E; Daley M
    Am J Health Syst Pharm; 2018 Sep; 75(17):1275-1285. PubMed ID: 29895520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First year experience of a pulmonary embolism response team with comparisons of outcomes between catheter directed therapy versus standard anticoagulation.
    Khaing P; Paruchuri A; Eisenbrey JR; Merli GJ; Gonsalves CF; West FM; Awsare BK
    Hosp Pract (1995); 2020 Feb; 48(1):23-28. PubMed ID: 31847615
    [No Abstract]   [Full Text] [Related]  

  • 8. Catheter-Directed Thrombolysis in Submassive Pulmonary Embolism and Acute Cor Pulmonale.
    Stein PD; Matta F; Hughes MJ
    Am J Cardiol; 2020 Sep; 131():109-114. PubMed ID: 32718549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Efficacy and Safety between Thrombolysis Plus Anticoagulation vs. Anticoagulation Alone for the Treatment of Acute Submassive Pulmonary Embolism: A Systematic Review and Meta-analysis.
    Pan Q; Gao H; Wang Y; Chen Q
    Curr Vasc Pharmacol; 2022; 20(6):491-500. PubMed ID: 35959626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of systemic versus catheter-based therapies: application of a prognostic model by a pulmonary embolism response team.
    Iskandar JP; Hariri E; Kanaan C; Kassis N; Kamran H; Sese D; Wright C; Marinescu M; Cameron SJ
    J Thromb Thrombolysis; 2022 Apr; 53(3):616-625. PubMed ID: 34586572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis.
    Kabrhel C; Ali A; Choi JG; Hur C
    Acad Emerg Med; 2017 Oct; 24(10):1235-1243. PubMed ID: 28650086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Catheter-Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism.
    Hennemeyer C; Khan A; McGregor H; Moffett C; Woodhead G
    Am J Med; 2019 Feb; 132(2):240-246. PubMed ID: 30367851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pragmatic Use of Catheter-Directed Thrombolysis in Venous Thromboembolism and a Comparative Evaluation With Traditional Therapies in Submassive Pulmonary Embolism.
    Bradley M; Bull T; Hountras P; MacLaren R
    J Pharm Pract; 2022 Oct; 35(5):738-746. PubMed ID: 33823705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-directed Thrombolysis
    Siordia JA; Kaur A
    Curr Cardiol Rev; 2022; 18(1):112-117. PubMed ID: 34082686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
    Tapson VF; Friedman O
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding, death, and costs of care during hospitalization for acute pulmonary embolism: Insights from the Saint Luke's Outcomes of Pulmonary Embolism (SLOPE) study.
    Bunte MC; Gosch K; Elkaryoni A; Noman A; Johnson E; Jones P; Indaram MB; Vupputuri S
    Vasc Med; 2021 Feb; 26(1):28-37. PubMed ID: 33227228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study.
    Lee JK; Chen WH; Lin YS; Chang CH; Chen TH
    Thromb Haemost; 2020 Aug; 120(8):1208-1216. PubMed ID: 32679597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
    Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome After Thrombolysis in Patients With Intermediate High-Risk Pulmonary Embolism: A Propensity Score Analysis.
    Zimmermann L; Laufs U; Petros S; Lenk K
    J Emerg Med; 2022 Mar; 62(3):378-389. PubMed ID: 35042625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Challenge of Intermediate-Risk Pulmonary Embolism.
    Weintraub SF; You J; Wilson S; Galmer A
    Am J Ther; 2023 Mar-Apr 01; 30(2):e134-e144. PubMed ID: 36811867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.